Background SARS-CoV-2 infection has, as of April 2021, affected> 133 million people
worldwide, causing> 2.5 million deaths. Because the large majority of individuals infected with …

… Audrey R Odom John Audrey R Odom John … Kathleen Chiotos, Hamid Bassiri, Edward
M Behrens, Allison M Blatz, Joyce Chang, Caroline Diorio, Julie C Fitzgerald, Alexis Topjian …

BACKGROUND Initial reports from the severe acute respiratory coronavirus 2 (SARS–CoV-2)
pandemic described children as being less susceptible to coronavirus disease 2019 (…

Red blood cells (RBCs) are essential for aerobic respiration through delivery of oxygen to
distant tissues. However, RBCs are currently considered immunologically inert, and few, if any, …

Most children with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
have mild or minimal disease, with a small proportion developing severe disease or …

Apicomplexan parasites secrete contents of the rhoptries, club-shaped organelles in the
apical region, into host cells to permit their invasion and establishment of infection. The rhoptry …

Background Understanding the prevalence and clinical presentation of coronavirus disease
2019 in pediatric patients can help healthcare providers and systems prepare and respond …

There are no proven safe and effective therapies for children who develop life‐threatening
complications of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). …

The last decade has seen an explosion of advanced assays for the diagnosis of infectious
diseases, yet evidence-based recommendations to inform their optimal use in the care of …

While the world awaits a widely available COVID-19 vaccine, availability of testing is limited
in many regions and can be further compounded by shortages of reagents, prolonged …